Genfit (ENXTPA:GNFT) Stock Slides As Wider Losses Deepen Turnaround DoubtsSimplywall·Sep 30, 2026 at 07:02 PMGNFT0.00%
Winton Capital Management discloses net short position in GenfitPUBT·Sep 29, 2026 at 01:45 PMGNFT0.00%
Genfit H1 net loss widens to EUR 26.12 million; revenue falls 37.07% to EUR 21.07 millionPUBT·Sep 28, 2026 at 06:13 PMGNFT0.00%
GNFT: H1 2026 saw strong royalty growth, expanded clinical pipeline, and a net loss of €26.1 millionQuartr·Sep 28, 2026 at 05:57 PMGNFT0.00%
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate UpdateUnusual Whales·Sep 28, 2026 at 05:53 PMGNFT0.00%
GNFT: Commercial success in PBC, diagnostic advances in MASH, and a strong pipeline drive future growthQuartr·Sep 15, 2026 at 03:05 PMGNFT0.00%
Genfit to launch Phase 2a nangibotide proof-of-concept trial in ACLF in Q4 2026PUBT·Sep 14, 2026 at 04:15 PMGNFT0.00%GNFTY0.00%
